CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 92 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.22 | $106K | 627,317 |
| 2026-09-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.82 | $120K | 652,317 |
| 2026-09-08 | Barber Daniel President and CEO | Option exercise | +91,743 | $0.96 | $88K | 677,317 |
| 2026-09-08 | Barber Daniel President and CEO | Option exercise · Warrant (Right to Buy) | −91,743 | 0 | ||
| 2026-08-17 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.29 | $107K | 585,574 |
| 2026-07-16 | Barber Daniel President and CEO | Sale 10b5-1 | −20,369 | $4.00 | $82K | 610,574 |
| 2026-07-15 | Barber Daniel President and CEO | Sale 10b5-1 | −4,631 | $4.03 | $19K | 630,943 |
| 2026-06-15 | Barber Daniel President and CEO | Sale 10b5-1 | −25,000 | $4.16 | $104K | 635,574 |
| 2026-05-15 | Barber Daniel President and CEO | Sale 10b5-1 | −8,257 | $4.29 | $35K | 660,574 |
| 2026-05-05 | Barber Daniel President and CEO | Shares withheld for taxes | −335,922 | $4.18 | $1.4M | 668,831 |
| 2026-03-10 | Barber Daniel President and CEO | Sale | −180,677 | $4.17 | $754K | 1,004,753 |
| 2026-03-09 | Barber Daniel President and CEO | Grant or award | +262,000 | 1,185,430 | ||
| 2026-03-09 | Barber Daniel President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +523,000 | $4.29 | $2.2M | 523,000 |
| 2025-09-26 | Barber Daniel President and CEO | Sale 10b5-1 | −91,343 | $6.03 | $551K | 923,430 |
| 2025-09-19 | Barber Daniel President and CEO | Sale 10b5-1 | −400 | $6.00 | $2K | 1,014,773 |
| 2025-03-09 | Barber Daniel President and CEO | Shares withheld for taxes | −53,998 | $2.65 | $143K | 1,015,173 |
| 2025-03-07 | Barber Daniel President and CEO | Grant or award · Performance Stock Units | +293,100 | 293,100 | ||
| 2025-03-07 | Barber Daniel President and CEO | Grant or award | +272,000 | 1,098,478 | ||
| 2025-03-07 | Barber Daniel President and CEO | Shares withheld for taxes | −29,307 | $2.65 | $78K | 1,069,171 |
| 2025-03-07 | Barber Daniel President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +408,000 | 408,000 |
Page 1 of 2 · 32 trades